NxStage Medical, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 40 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-11: Reporting owner REID PERPER; Form 4; Security Stock option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-12-10: Reporting owner Brown Robert S.; Form 4; Security Stock option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-12-10: Reporting owner Brown Robert S.; Form 4; Security Stock option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-12-10: Reporting owner Burbank Jeffrey H; Form 4; Security Stock option (right to buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-11 | REID PERPER Director | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,000 0 owned after | $3.38 exercise price | 2013-12-13 | |
| 2013-12-10 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,630 45,370 owned after | $4.54 exercise price | 2013-12-12 | |
| 2013-12-10 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,175 10,825 owned after | $2.11 exercise price | 2013-12-12 | |
| 2013-12-10 | Burbank Jeffrey H Director, Officer (CEO) | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,735 0 owned after | $5.47 exercise price | 2013-12-12 | |
| 2013-12-10 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,997 0 owned after | $5.47 exercise price | 2013-12-11 | |
| 2013-12-10 | Turk Joseph E Jr Officer (President) | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −13,986 0 owned after | $5.47 exercise price | 2013-12-11 | |
| 2013-12-10 | Turk Joseph E Jr Officer (President) | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,436 19,800 owned after | $6.84 exercise price | 2013-12-11 | |
| 2013-11-19 | Burbank Jeffrey H Director, Officer (CEO) | 4 | Stock option (right to buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,868 20,735 owned after | $5.47 exercise price | 2013-11-20 | |
| 2013-10-21 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −75,309 0 owned after | $8.92 exercise price | 2013-10-22 | |
| 2013-10-18 | Brown Robert S. Officer (President, Kidney Care) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −64,791 75,309 owned after | $8.92 exercise price | 2013-10-22 | |
| 2013-07-15 | TOWSE MATTHEW W Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +69,119 69,119 owned after | $14.05 exercise price | 2013-07-16 | |
| 2013-07-08 | Shea Thomas Officer (SVP Manufacturing Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 80,000 owned after | $4.32 exercise price | 2013-07-10 | |
| 2013-07-02 holding as of filing | Hershberger Kevin Officer (Chief Accounting Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $2.11 exercise price | 2013-07-02 | ||
| 2013-07-02 holding as of filing | Hershberger Kevin Officer (Chief Accounting Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $4.85 exercise price | 2013-07-02 | ||
| 2013-07-02 holding as of filing | Hershberger Kevin Officer (Chief Accounting Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $9.96 exercise price | 2013-07-02 | ||
| 2013-07-02 holding as of filing | Hershberger Kevin Officer (Chief Accounting Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $18.59 exercise price | 2013-07-02 | ||
| 2013-07-02 holding as of filing | Hershberger Kevin Officer (Chief Accounting Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $18.48 exercise price | 2013-07-02 | ||
| 2013-07-02 holding as of filing | Hershberger Kevin Officer (Chief Accounting Officer) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $11.03 exercise price | 2013-07-02 | ||
| 2013-06-20 | Shreiner Jay W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,063 16,063 owned after | $14.12 exercise price | 2013-06-24 | |
| 2013-06-10 | Shea Thomas Officer (SVP Manufacturing Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 85,000 owned after | $4.32 exercise price | 2013-06-10 | |
| 2013-05-23 | Straube Barry M Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,196 18,196 owned after | $13.60 exercise price | 2013-05-28 | |
| 2013-05-23 | REID PERPER Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,196 18,196 owned after | $13.60 exercise price | 2013-05-28 | |
| 2013-05-23 | MOORE CRAIG W Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,196 18,196 owned after | $13.60 exercise price | 2013-05-28 | |
| 2013-05-23 | Mixer Jean K Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,196 18,196 owned after | $13.60 exercise price | 2013-05-28 | |
| 2013-05-23 | LEWIS EARL R Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,196 18,196 owned after | $13.60 exercise price | 2013-05-28 | |
| 2013-05-23 | Giannini Daniel A Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,196 18,196 owned after | $13.60 exercise price | 2013-05-28 | |
| 2013-05-23 | FUNARI ROBERT G Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,196 18,196 owned after | $13.60 exercise price | 2013-05-28 | |
| 2013-05-13 | Shea Thomas Officer (SVP Manufacturing Operations) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,724 4,276 owned after | $2.11 exercise price | 2013-05-14 | |
| 2013-03-13 | MOORE CRAIG W Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $5.39 exercise price | 2013-03-14 | |
| 2013-03-12 | Giannini Daniel A Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $5.39 exercise price | 2013-03-13 | |
| 2013-03-05 | REID PERPER Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,000 0 owned after | $5.39 exercise price | 2013-03-06 | |
| 2013-03-04 | Snell Todd M Officer (SVP, QA, Reg.&Clinical Affairs) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,186 41,186 owned after | $11.03 exercise price | 2013-03-06 | |
| 2013-03-04 | Shea Thomas Officer (SVP Manufacturing Operations) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +41,186 41,186 owned after | $11.03 exercise price | 2013-03-06 | |
| 2013-03-04 | Swan Winifred L Officer (SVP and General Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +53,542 53,542 owned after | $11.03 exercise price | 2013-03-06 | |
| 2013-03-04 | Turk Joseph E Jr Officer (President, North America) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,897 65,897 owned after | $11.03 exercise price | 2013-03-06 | |
| 2013-03-04 | Burbank Jeffrey H Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +189,456 189,456 owned after | $11.03 exercise price | 2013-03-06 | |
| 2013-03-04 | Brown Robert S. Officer (Sr. Vice President, CFO) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,897 65,897 owned after | $11.03 exercise price | 2013-03-06 | |
| 2013-01-30 | Turk Joseph E Jr Officer (President, North America) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,989 0 owned after | $4.10 | 2013-01-31 | |
| 2013-01-22 | FUNARI ROBERT G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +7,173 7,173 owned after | $11.27 exercise price | 2013-01-24 | |
| 2013-01-02 | Burbank Jeffrey H Director, Officer (President & CEO) | 4/A | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,560 0 owned after | $4.10 | 2013-01-11 |